As Teva Pharmaceutical Industries LTD (TEVA) Shares Declined, Dreman Value Management Increased Stake by $448,834; Coho Partners LTD Cut Its Cvs Health (CVS) Position by $12.01 Million as Share Value Declined

January 13, 2018 - By Richard Conner

David Dreman increased its stake in Teva Pharmaceutical Industries Ltd. (TEVA) by 168.75% based on its latest 2017Q3 regulatory filing with the SEC. Dreman Value Management Llc bought 26,402 shares as the company’s stock declined 15.11% while stock markets rallied. The hedge fund run by David Dreman held 42,048 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $740,000, up from 15,646 at the end of the previous reported quarter. Dreman Value Management Llc who had been investing in Teva Pharmaceutical Industries Ltd. for a number of months, seems to be bullish on the $22.42B market cap company. The stock increased 1.52% or $0.33 during the last trading session, reaching $22.07. About 40.56M shares traded or 52.06% up from the average. Teva Pharmaceutical Industries Limited (NYSE:TEVA) has declined 41.70% since January 13, 2017 and is downtrending. It has underperformed by 58.40% the S&P500.

Coho Partners Ltd decreased its stake in Cvs Health Corporation (CVS) by 6.44% based on its latest 2017Q3 regulatory filing with the SEC. Coho Partners Ltd sold 148,246 shares as the company’s stock declined 4.23% while stock markets rallied. The institutional investor held 2.15 million shares of the medical and nursing services company at the end of 2017Q3, valued at $175.17M, down from 2.30 million at the end of the previous reported quarter. Coho Partners Ltd who had been investing in Cvs Health Corporation for a number of months, seems to be less bullish one the $79.81 billion market cap company. The stock decreased 0.30% or $0.24 during the last trading session, reaching $78.78. About 7.10M shares traded. CVS Health Corporation (NYSE:CVS) has declined 24.40% since January 13, 2017 and is downtrending. It has underperformed by 41.10% the S&P500.

Dreman Value Management Llc, which manages about $2.21B and $182.49 million US Long portfolio, decreased its stake in Manpower Inc. (NYSE:MAN) by 4,818 shares to 67 shares, valued at $8,000 in 2017Q3, according to the filing. It also reduced its holding in Ca Inc Common Stock Usd.1 (NASDAQ:CA) by 10,230 shares in the quarter, leaving it with 31,682 shares, and cut its stake in Apple Computer (NASDAQ:AAPL).

Among 33 analysts covering Teva Pharma (NYSE:TEVA), 9 have Buy rating, 7 Sell and 17 Hold. Therefore 27% are positive. Teva Pharma had 127 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has “Equal-Weight” rating given on Wednesday, November 16 by Morgan Stanley. The rating was maintained by Cantor Fitzgerald on Thursday, June 22 with “Hold”. The company was maintained on Wednesday, October 4 by Oppenheimer. The firm earned “Buy” rating on Tuesday, January 9 by Mizuho. As per Friday, July 14, the company rating was maintained by Oppenheimer. Standpoint Research maintained Teva Pharmaceutical Industries Limited (NYSE:TEVA) on Monday, July 27 with “Buy” rating. Goldman Sachs upgraded Teva Pharmaceutical Industries Limited (NYSE:TEVA) rating on Thursday, January 11. Goldman Sachs has “Buy” rating and $25.0 target. Citigroup maintained the stock with “Neutral” rating in Monday, November 13 report. The stock of Teva Pharmaceutical Industries Limited (NYSE:TEVA) earned “Hold” rating by Jefferies on Thursday, June 22. RBC Capital Markets maintained it with “Outperform” rating and $85 target in Wednesday, July 29 report.

Analysts await CVS Health Corporation (NYSE:CVS) to report earnings on February, 8. They expect $1.90 earnings per share, up 11.11% or $0.19 from last year’s $1.71 per share. CVS’s profit will be $1.92B for 10.37 P/E if the $1.90 EPS becomes a reality. After $1.50 actual earnings per share reported by CVS Health Corporation for the previous quarter, Wall Street now forecasts 26.67% EPS growth.

Coho Partners Ltd, which manages about $1.39 billion and $3.90 billion US Long portfolio, upped its stake in The Kroger Co. (NYSE:KR) by 2.34 million shares to 5.94M shares, valued at $119.06 million in 2017Q3, according to the filing.

Investors sentiment decreased to 0.88 in Q3 2017. Its down 0.04, from 0.92 in 2017Q2. It turned negative, as 60 investors sold CVS shares while 571 reduced holdings. 88 funds opened positions while 466 raised stakes. 801.45 million shares or 0.31% less from 803.96 million shares in 2017Q2 were reported. Adirondack Trust reported 11,198 shares. Bellecapital Limited stated it has 28,477 shares or 2.73% of all its holdings. Beacon Fin Group Inc has invested 0.94% in CVS Health Corporation (NYSE:CVS). 112,905 are held by Associated Banc. Americafirst Capital Mngmt Lc owns 5,156 shares or 0.57% of their US portfolio. Moreover, Psagot Invest House has 0.19% invested in CVS Health Corporation (NYSE:CVS). The New Jersey-based Tradition Capital Management Lc has invested 0.11% in CVS Health Corporation (NYSE:CVS). North Tide Capital Ltd Liability Company has invested 4.34% in CVS Health Corporation (NYSE:CVS). Augustine Asset Mngmt has invested 1.78% in CVS Health Corporation (NYSE:CVS). 335,581 were reported by Citadel Advisors Limited Liability Corp. First Interstate State Bank accumulated 0.07% or 4,199 shares. Illinois-based Westwood Management Corporation Il has invested 0.05% in CVS Health Corporation (NYSE:CVS). 124,714 are held by Old National Savings Bank In. Ntv Asset Mngmt Lc invested 0.06% in CVS Health Corporation (NYSE:CVS). 1.57 million are held by Brandywine Global Mngmt Lc.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>